Now that Amylin ($AMLN) and Human Genome Sciences ($HGSI) have completed their buyout deals, the biotech industry is virtually humming with gossip about the next sizable acquisition. Report
Now that Amylin ($AMLN) and Human Genome Sciences ($HGSI) have completed their buyout deals, the biotech industry is virtually humming with gossip about the next sizable acquisition. Report